Alpha/Beta Interferon and Gamma Interferon Synergize To Inhibit the Replication of Herpes Simplex Virus Type 1
暂无分享,去创建一个
[1] E. Cantin,et al. Role for Gamma Interferon in Control of Herpes Simplex Virus Type 1 Reactivation , 1999, Journal of Virology.
[2] M. Farrar,et al. The molecular cell biology of interferon-gamma and its receptor. , 1993, Annual review of immunology.
[3] K. Cantell. Development of antiviral therapy with alpha interferons: promises, false hopes and accomplishments. , 1995, Annals of medicine.
[4] D. Tscharke,et al. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons , 1992, The Journal of experimental medicine.
[5] F. Chisari,et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. , 1996, Immunity.
[6] L. Corey,et al. Tipping the scales of herpes simplex virus reactivation: The important responses are local , 1998, Nature Medicine.
[7] W. Coulter,et al. Oral shedding of herpes simplex virus type 1: a review. , 1997, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[8] R. Silverman,et al. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[9] W. Halford,et al. Optimized Viral Dose and Transient Immunosuppression Enable Herpes Simplex Virus ICP0-Null Mutants To Establish Wild-Type Levels of Latency In Vivo , 2000, Journal of Virology.
[10] P. Pitha,et al. Expression of human and macaque type I IFN transgenes interferes with HSV-1 replication at the transcriptional and translational levels: IFN-β is more potent than IFN-α2 , 2001 .
[11] A. Ellison,et al. Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[12] L. Corey,et al. Herpesvirus infections in persons infected with human immunodeficiency virus. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] L. Corey,et al. Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. , 1998, The Journal of clinical investigation.
[14] H. Field,et al. Famciclovir and Valaciclovir Differ in the Prevention of Herpes Simplex Virus Type 1 Latency in Mice: a Quantitative Study , 1998, Antimicrobial Agents and Chemotherapy.
[15] M. E. Abrams,et al. Enhanced Inhibition of Herpes Simplex Virus Type 1 Growth in Human Corneal Fibroblasts by Combinations of Interferon-α and -γ , 1992 .
[16] S. Straus,et al. Gamma Interferon Impedes the Establishment of Herpes Simplex Virus Type 1 Latent Infection but Has No Impact on Its Maintenance or Reactivation in Mice , 2000, Journal of Virology.
[17] D. Fink,et al. Cd8+ T Cells Can Block Herpes Simplex Virus Type 1 (HSV-1) Reactivation from Latency in Sensory Neurons , 2000, The Journal of experimental medicine.
[18] E. D. Maloney,et al. IDU therapy of herpes simplex. , 1962, Archives of ophthalmology.
[19] J. Orange,et al. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration , 1995, The Journal of experimental medicine.
[20] A. Nash,et al. Effect of Acycloguanosine Treatment on Acute and Latent Herpes Simplex Infections in Mice , 1979, Antimicrobial Agents and Chemotherapy.
[21] E. Falcoff,et al. Synergistic activities of type I (alpha, beta) and type II (gamma) murine interferons. , 1982, Antiviral research.
[22] I. Campbell,et al. Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis. , 1999, Journal of immunology.
[23] L. Stanberry,et al. Herpes simplex viremia: report of eight pediatric cases and review of the literature. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] D. Moore,et al. Preparation and Analysis of DNA , 2002 .
[25] A. Thomson. The cytokine handbook , 1994 .
[26] B. Gebhardt,et al. The inherent quantitative capacity of the reverse transcription-polymerase chain reaction. , 1999, Analytical biochemistry.
[27] C. Samuel,et al. Reoviruses and the interferon system. , 1998, Current topics in microbiology and immunology.
[28] R. Tal-Singer,et al. Effect of Famciclovir on Herpes Simplex Virus Type 1 Corneal Disease and Establishment of Latency in Rabbits , 2001, Antimicrobial Agents and Chemotherapy.
[29] J. Zeh,et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. , 2000, The New England journal of medicine.
[30] H. Dockrell. The Cytokine Handbook , 1993 .
[31] S. Straus,et al. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice. , 1999, The Journal of infectious diseases.
[32] B. Rouse,et al. Herpetic stromal keratitis in the reconstituted scid mouse model , 1993, Journal of virology.
[33] R. Sobel,et al. In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis , 1999, Journal of Neuroimmunology.
[34] W. Halford,et al. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. , 2002, Virology.
[35] R. Chervenak,et al. Control of acute cutaneous herpes simplex virus infection : T cell-mediated viral clearance is dependent upon interferon-γ (IFN-γ) , 1994 .
[36] Ting Liu,et al. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection , 1996, Journal of virology.
[37] W. Halford,et al. ICP0, ICP4, or VP16 Expressed from Adenovirus Vectors Induces Reactivation of Latent Herpes Simplex Virus Type 1 in Primary Cultures of Latently Infected Trigeminal Ganglion Cells , 2001, Journal of Virology.
[38] F. Chisari,et al. Recombinant Duck Interferon Gamma Inhibits Duck Hepatitis B Virus Replication in Primary Hepatocytes , 1999, Journal of Virology.
[39] W. Halford. The essential prerequisites for quantitative RT-PCR , 1999, Nature Biotechnology.
[40] W. Halford,et al. Quantitative analysis of polymerase chain reaction products by dot blot. , 1996, Analytical biochemistry.
[41] D. Easty,et al. Immune cell infiltration in corneas of mice with recurrent herpes simplex virus disease. , 1996, Journal of General Virology.
[42] B. Gebhardt,et al. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. , 1996, Journal of immunology.
[43] G. J. Buddingh,et al. Studies of the natural history of herpes simplex infections. , 1953, Pediatrics.
[44] E. Cantin,et al. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1 , 1995, Journal of virology.
[45] J. Sugar,et al. Effect of exogenous interferon on herpetic keratitis in rabbits and monkeys. , 1973, Investigative ophthalmology.
[46] J. Zeh,et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. , 1997, The Journal of clinical investigation.
[47] M. Ho. Interferon as an agent against herpes simplex virus. , 1990, The Journal of investigative dermatology.
[48] B. Bloom,et al. Role of NK cells in protection of mice against herpes simplex virus-1 infection. , 1987, Journal of immunology.
[49] J. Bluestone,et al. T Cell Receptor–γ/δ Cells Protect Mice from Herpes Simplex Virus Type 1–induced Lethal Encephalitis , 1997, The Journal of experimental medicine.
[50] B. Roizman,et al. The Second-Site Mutation in the Herpes Simplex Virus Recombinants Lacking the γ134.5 Genes Precludes Shutoff of Protein Synthesis by Blocking the Phosphorylation of eIF-2α , 1998, Journal of Virology.
[51] M. J. Betts,et al. Carbapenems: the pinnacle of the β-lactam antibiotics or room for improvement? , 2000 .
[52] F. Chisari,et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[53] R. Chervenak,et al. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma). , 1994, Virology.
[54] E. Cantin,et al. Gamma Interferon (IFN-γ) Receptor Null-Mutant Mice Are More Susceptible to Herpes Simplex Virus Type 1 Infection than IFN-γ Ligand Null-Mutant Mice , 1999, Journal of Virology.
[55] E. Falcoff,et al. Synergistic activities of type I (α, β) and type II (γ) murine interferons , 1982 .
[56] G. Kinghorn. Epidemiology of genital herpes. , 1994, The Journal of international medical research.
[57] K. Smith,et al. Relationship Between the Envelope and the Infectivity of Herpes Simplex Virus.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[58] F. Chisari,et al. Inhibition of Hepatitis B Virus Replication by Interferon Requires Proteasome Activity† , 2002, Journal of Virology.
[59] K. Mossman,et al. Herpes Simplex Virus ICP0 Mutants Are Hypersensitive to Interferon , 2000, Journal of Virology.
[60] A. Wald,et al. Herpes simplex virus: the importance of asymptomatic shedding. , 2000, The Journal of antimicrobial chemotherapy.
[61] K. Khanna,et al. Gamma Interferon Can Prevent Herpes Simplex Virus Type 1 Reactivation from Latency in Sensory Neurons , 2001, Journal of Virology.
[62] D. Easty,et al. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1 , 1995, Journal of Neuroimmunology.
[63] M. Brunda,et al. Interferons and Other Cytokines , 1997 .
[64] G. Rall,et al. Immune-Mediated Protection from Measles Virus-Induced Central Nervous System Disease Is Noncytolytic and Gamma Interferon Dependent , 2002, Journal of Virology.
[65] K. Mossman,et al. Herpes Simplex Virus ICP0 and ICP34.5 Counteract Distinct Interferon-Induced Barriers to Virus Replication , 2002, Journal of Virology.
[66] D. Estell,et al. Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons , 1984, Journal of virology.
[67] B. Gebhardt,et al. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1. , 1997, Virology.